{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:18:45Z","timestamp":1791685125786,"version":"4.3.4"},"reference-count":58,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"3","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2020,2,27]]},"DOI":"10.1167\/tvst.9.3.30","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T13:30:38Z","timestamp":1582810238000},"page":"30","source":"Crossref","is-referenced-by-count":37,"title":["Safety and Biocompatibility of Aflibercept-Loaded Microsphere Thermo-Responsive Hydrogel Drug Delivery System in a Nonhuman Primate Model"],"prefix":"10.1167","volume":"9","author":[{"given":"Soohyun","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Kang-Mieler","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Yiu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Science, School of Medicine, University of California-Davis, Davis, CA,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro B. C.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Mieler","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Thomasy","sequence":"additional","affiliation":[{"name":"Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA,USA"},{"name":"Department of Ophthalmology and Vision Science, School of Medicine, University of California-Davis, Davis, CA,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","first-page":"5397","article-title":"Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis","volume":"9","author":"Ba","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ajo.2014.06.006","article-title":"Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edema","volume":"158","author":"You","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"pii:E1498","DOI":"10.3390\/ijms17091498","article-title":"Moving past anti-VEGF: novel therapies for treating diabetic retinopathy","volume":"17","author":"Bolinger","year":"2016","journal-title":"Int J Mol Sci"},{"key":"bib4","first-page":"546","article-title":"Update on the use of anti-VEGF intravitreal therapies for retinal vein occlusion","volume":"6","author":"Jiang","year":"2017","journal-title":"Asia-Pac J Ophthalmol"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s10792-017-0536-0","article-title":"Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy","volume":"38","author":"Barth","year":"2018","journal-title":"Int Ophthalmol"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/ICB.0000000000000504","article-title":"Outcomes of anti-VEGF therapy in choroidal neovascularization after macular surgery","volume":"12","author":"Hua","year":"2018","journal-title":"Retin Cases Brief Rep"},{"key":"bib7","doi-asserted-by":"crossref","first-page":"e706","DOI":"10.1111\/aos.14046","article-title":"Ling-term outcomes of switching to aflibercept for treatment-resistant neovascular age-related macular degeneration","volume":"97","author":"Spooner","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/ICU.0b013e32835fefee","article-title":"Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration","volume":"24","author":"Scott","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.oret.2017.01.004","article-title":"Long-term safety and visual outcome of intravitreal aflibercept in neovascular age-related macular degeneration","volume":"1","author":"Kaiser","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"bib10","first-page":"434","article-title":"Pharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor Trap-eye)","volume":"32","author":"Stewart","year":"2012","journal-title":"Retina"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12348-015-0069-5","article-title":"Endophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual micro-organisms","volume":"6","author":"Sachdeva","year":"2016","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/08820538.2017.1353811","article-title":"Complications of intravitreous injections in patients with diabetes","volume":"33","author":"Gupta","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000486145","article-title":"2018 update on intravitreal injections: Euretina expert consensus recommendations","volume":"239","author":"Grzybowski","year":"2018","journal-title":"Ophthalmolgica"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.oret.2017.12.006","article-title":"Medicare spending on anti-vascular endothelial growth factor medications","volume":"2","author":"Patel","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/jps.21987","article-title":"A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases","volume":"99","author":"Choonara","year":"2010","journal-title":"J Pham Sci"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1517\/17425247.2014.935338","article-title":"Advances in ocular drug delivery: emphasis on the posterior segment","volume":"11","author":"Kang-Mieler","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s10439-015-1314-7","article-title":"Controlled and extended release of a model protein from a microsphere-hydrogel drug delivery system","volume":"43","author":"Osswald","year":"2015","journal-title":"Ann Biomed Eng"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3109\/02713683.2015.1101140","article-title":"Controlled and extended in vitro release of bioactive anti-vascular endothelial growth factors from a microsphere-hydrogel drug delivery system","volume":"41","author":"Osswald","year":"2016","journal-title":"Curr Eye Res"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1081\/MC-100100578","article-title":"Phase transition in linear and cross-linked poly(N-isopropylacrylamide) in water: effect of various types of additives","volume":"40","author":"Dhara","year":"2000","journal-title":"J Macromol Sci Rev Macromol Chem Phys"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1080\/02713683.2017.1302590","article-title":"In vivo efficacy of an injectable microsphere-hydrogel ocular drug delivery system","volume":"42","author":"Osswald","year":"2017","journal-title":"Curr Eye Res"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijpharm.2016.01.011","article-title":"Hydrophobic ion pairing of an minocycline\/Ca(2+)\/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release","volume":"499","author":"Holmkvist","year":"2016","journal-title":"Int J Pharm"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/10837450.2016.1264415","article-title":"Preparation and characterization of bee venom-loaded PLGA particles for sustained release","volume":"23","author":"Park","year":"2018","journal-title":"Pharm Dev Technol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/02713683.2018.1533983","article-title":"Biodegradable microsphere-hydrogel ocular drug delivery system for controlled and extended release of bioactive aflibercept in vitro","volume":"44","author":"Liu","year":"2019","journal-title":"Curr Eye Res"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s11095-013-1195-0","article-title":"The effect of glutathione as chain transfer agent in PNIPAAm-based thermo-responsive hydrogels for controlled release of proteins","volume":"31","author":"Darpala","year":"2014","journal-title":"Pharm Res"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1089\/jop.2017.0108","article-title":"The SPOTS system: an ocular scoring system optimized for use in modern preclinical drug development and toxicology","volume":"33","author":"Eaton","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","article-title":"ISCEV standard for full-field clinical electroretinography (2015 update)","volume":"130","author":"McCulloch","year":"2015","journal-title":"Doc Ophthalmol"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3109\/02713689608995150","article-title":"Human vitreous hyaluronidase: isolation and characterization","volume":"15","author":"Schwartz","year":"1996","journal-title":"Curr Eye Res"},{"key":"bib28","first-page":"785","article-title":"Intraocular pressure of rhesus monkey (Macaca mulatta). I. An initial survey of two free-breeding colonies","volume":"18","author":"Bito","year":"1979","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","article-title":"Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab","volume":"15","author":"Papadopoulos","year":"2012","journal-title":"Angiogenesis"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1016\/j.biomaterials.2011.01.058","article-title":"The effects of cross-linked thermo-responsive PNIPAAM-based hydrogel injection on retinal function","volume":"32","author":"Turturro","year":"2011","journal-title":"Biomaterials"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.8.1.12","article-title":"Characterization of biodegradable microsphere-hydrogel ocular drug delivery system for controlled and extended releases of ranibizumab","volume":"8","author":"Liu","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2016.10.026","article-title":"Single ocular injection of a sustained-release anti-VEGF delivers 6months pharmacokinetics and efficacy in a primate laser CNV model","volume":"244","author":"Adamson","year":"2016","journal-title":"J Control Release"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.biopha.2018.08.138","article-title":"A review on recent drug delivery systems for posterior segment of eye","volume":"107","author":"Nayak","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1167\/iovs.16-21334","article-title":"Evaluation of the toxicity of intravitreally injected PLGA microspheres and rods in monkeys and rabbits: effects of depot size on inflammatory response","volume":"58","author":"Thackaberry","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1167\/iovs.12-10260","article-title":"Pharmacokinetics of ranibizumab in patients with neovascular age-related macular degeneration: a population approach","volume":"54","author":"Xu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug Discov Today"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejpb.2015.01.003","article-title":"Intravitreal clearance and volume of distribution of compounds in rabbits: in silico prediction and pharmacokinetic simulations for drug development","volume":"95","author":"Del Amo","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1021\/acs.molpharmaceut.8b00280","article-title":"Theoretical insights into the retinal dynamics of vascular endothelial growth factor in patients treated with ranibizumab, based on an ocular pharmacokinetic\/pharmacodynamic model","volume":"15","author":"Hutton-Smith","year":"2018","journal-title":"Mol Pharm"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3928\/23258160-20121221-08","article-title":"Acute anterior uveitis following intravitreal injection of bevacizumab","volume":"44","author":"Mozayan","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.actbio.2017.09.023","article-title":"Discerning the composition of penetratin for safe penetration from cornea to retina","volume":"63","author":"Jiang","year":"2017","journal-title":"Acta Biomater"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1021\/acs.molpharmaceut.7b00128","article-title":"Topical formulation of self-assembled antiviral progrug nanomicelles for targeted retinal delivery","volume":"14","author":"Mandal","year":"2017","journal-title":"Mol Pharm"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/jop.2012.0044","article-title":"A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema","volume":"29","author":"Daull","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/jop.2012.0128","article-title":"Lipid nanoparticles as drug\/gene delivery systems to the retina","volume":"29","author":"Del Pozo-Rodriguez","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib46","first-page":"1038","article-title":"Nanotechnology in retinal drug delivery","volume":"11","author":"Jiang","year":"2018","journal-title":"Int J Ophthalmol"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jconrel.2018.03.001","article-title":"Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle","volume":"277","author":"Jung","year":"2018","journal-title":"J Control Release"},{"key":"bib48","first-page":"206","article-title":"Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye","volume":"106","author":"Kang Derwent","year":"2008","journal-title":"Trans Am Ophthalmol Soc"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajps.2018.04.008","article-title":"Research progress of in-situ gelling ophthalmic drug delivery system","volume":"14","author":"Wu","year":"2019","journal-title":"Asian J Pharm Sci"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1021\/acs.molpharmaceut.7b00291","article-title":"Hydrophobically modified polymer\/a-cyclodextrin thermoresponsive hydrogels for use in ocular drug delivery","volume":"14","author":"Iohara","year":"2017","journal-title":"Mol Pharm"},{"key":"bib51","first-page":"460","article-title":"Loratadine-loaded thermoresponsive hydrogel: characterization and ex-vivo rabbit cornea permeability studies","volume":"17","author":"Sharif Makhmalzadeh","year":"2018","journal-title":"Iran J Pharm Res"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejpb.2017.01.008","article-title":"Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: design, characterization, toxicity and transcorneal permeation studies","volume":"114","author":"M A Fathalla","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1126\/scitranslmed.aan3879","article-title":"A reversible thermoresponsive sealant for temporary closure of ocular trauma","volume":"9:","author":"Bayat","year":"2017","journal-title":"Sci Transi Med"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/jphp.12152","article-title":"Microneedle-mediated intrascleral delivery of in situ forming thermoresponsive implants for sustained ocular drug delivery","volume":"66","author":"Thakur","year":"2014","journal-title":"J Pharm Pharmacol"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"261656","DOI":"10.1371\/journal.pone.0061656","article-title":"Global and ocular hypothermic preconditioning protect the rat retina from ischemic damage","volume":"8","author":"Salido","year":"2013","journal-title":"PLoS One"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"6593","DOI":"10.1167\/iovs.10-5659","article-title":"The relationship between body and ambient temperature and corneal temperature","volume":"51","author":"Kessel","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1167\/iovs.13-13065","article-title":"Changes in vitreous temperature during intravitreal surgery","volume":"55","author":"Iguchi","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.mam.2012.06.003","article-title":"Animal models of age-related macular degeneration","volume":"33","author":"Pennesi","year":"2012","journal-title":"Mol Aspects Med"},{"key":"bib35","volume-title":"Summary of approval\u2013Eylea (aflibercept): proposed indication: treatment of patients with neovascular (wet) age-related macular degeneration (AMD)","author":"Food and Drug Administration.","year":"2011"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2762345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T13:30:42Z","timestamp":1582810242000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2762345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2,7]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.9.3.30","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,27]]}}}